pi3k/brd4

SF1126 is a relevant pan and dual first-in-class PI3K BRD4 inhibitor. SF1126 is an RGDS-conjugated LY294002 prodrug, which is designed to exhibit increased solubility and bind to specific integrins within the tumor compartment.

SF2523 是一种选择性PI3K 抑制剂，抑制DNA-PK、PI3Kα、PI3Kγ、BRD4 和 mTOR，IC50分别为 9 nM、34 nM、158 nM、241 nM 和 280 nM。

SRX3177 是一种新型强效的抑制剂，对 BRD4、PI3K 和 CDK 有抑制作用。SRX3177 具有潜在的抗癌活性。